Open AccessTracheal intubation with volatile induction and target bispectral index of 25 versus 40: A randomized clinical trial
Author(s) -
Purva Khandelwal,
K. K. Gombar,
Vanita Ahuja,
Satinder Gombar
Publication year - 2016
Publication title -
journal of anaesthesiology-clinical pharmacology/journal of anaesthesiology clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.466
H-Index - 32
eISSN - 2231-2730
pISSN - 0970-9185
DOI - 10.4103/0970-9185.188831
Subject(s) - medicine , intubation , tracheal intubation , bispectral index , anesthesia , randomized controlled trial , sevoflurane , adverse effect , clinical trial , rocuronium , surgery , propofol
A target bispectral index (BIS) value of 40 is considered adequate for depth of anesthesia, but no consensus exists regarding BIS value for tracheal intubation without neuromuscular blocking drugs. The aim of this randomized, double-blinded study was to compare the total duration from sevoflurane induction to tracheal intubation at a BIS value of 25 or 40.